MTERF2: A Potential Drug Target and Biomarker (G80298)

Target Name: MTERF2

NCBI ID: G80298

MTERF2

MTERF2: A Potential Drug Target and Biomarker

MTerf2, also known as MTerf-like, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the metal transmembrane protein family Mammalian Transmembrane Protein 2 (MTBP2) family, which includes several other proteins that play important roles in cellular signaling and signaling pathways.

MTerf2 has been shown to play a role in several cellular processes, including the regulation of ion channels, cell signaling, and neurotransmitter release. It has also been shown to be involved in several diseases, including epilepsy, Parkinson's disease, and neurodegenerative diseases.

One of the key challenges in studying MTerf2 is its complex structure and the difficulty in purifying and recombinating it. Despite these challenges, research into MTerf2 has led to several new insights into its functions and potential as a drug target.

In addition to its role in cellular signaling, MTerf2 has also been shown to play a role in the regulation of ion channels. It is a member of the TRPV4 receptor subfamily, which is involved in the regulation of pain, inflammation, and neurotransmission. MTerf2 has been shown to interact with this receptor and play a role in its function.

In addition to its role in ion channels, MTerf2 has also been shown to be involved in the regulation of cell signaling pathways. It is a member of the PDGF receptor family, which is involved in cell signaling and growth. play a role in the regulation of PDGF signaling and has been shown to be involved in the development of neurodegenerative diseases.

In addition to its role in cell signaling, MTerf2 has also been shown to be involved in the regulation of neurotransmission. It is a member of the NMJ Receptor protein family, which is involved in the regulation of neurotransmission. MTerf2 has also been shown to play a role in the regulation of neurotransmission in the brain and has been shown to be involved in the development of neurodegenerative diseases.

Despite its involvement in several cellular processes, MTerf2 has not yet been shown to be a drug target. However, research into its functions and potential as a drug target is ongoing.

In conclusion, MTerf2 is a protein that has been shown to play a role in several cellular processes, including the regulation of ion channels, cell signaling pathways, and neurotransmission. Its complex structure and the difficulty in purifying and recombinating it make it a challenging target for drug development. However, research into its functions and potential as a drug target is ongoing, and further studies are needed to fully understand its role in disease.

Protein Name: Mitochondrial Transcription Termination Factor 2

Functions: Binds mitochondrial DNA and plays a role in the regulation of transcription of mitochondrial mRNA and rRNA species

The "MTERF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTERF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets